Bulletin
Investor Alert

London Markets Open in:

CymaBay Therapeutics Inc.

NAS: CBAY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 18, 2020, 7:52 p.m.

/zigman2/quotes/201917619/composite

$

6.88

Change

-0.04 -0.58%

Volume

Volume 55,805

Quotes are delayed by 20 min

/zigman2/quotes/201917619/composite

Previous close

$ 6.55

$ 6.92

Change

+0.37 +5.65%

Day low

Day high

$6.52

$6.95

Open

52 week low

52 week high

$1.21

$7.09

Open

Insider Actions for CymaBay Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/10/2019 Sujal Shah
Chief Executive Officer; Director
5,000   Acquisition at $4.3 per share. 21,500
09/23/2019 Sujal Shah
Chief Executive Officer; Director
3,100   Acquisition at $5.55 per share. 17,205
09/20/2019 Sujal Shah
Chief Executive Officer; Director
1,900   Acquisition at $5.5 per share. 10,450
02/07/2019 Carl Samuel Goldfischer
Director
11,675   Disposition at $9.02 per share. 105,308
02/07/2019 Carl Samuel Goldfischer
Director
9,340   Derivative/Non-derivative trans. at $5.5 per share. 51,370
02/07/2019 Carl Samuel Goldfischer
Director
2,335   Derivative/Non-derivative trans. at $5 per share. 11,675
12/21/2018 Sujal Shah
Chief Executive Officer; Director
10,000   Acquisition at $6.54 per share. 65,400
12/18/2018 Abingworth LLP
Director
53,492   Disposition at $7.43 per share. 397,445
12/17/2018 Abingworth LLP
Director
88,889   Disposition at $8.17 per share. 726,223
10/15/2018 Sujal Shah
Chief Executive Officer; Director
5,000   Acquisition at $9.9 per share. 49,500
08/29/2018 Daniel Menold
Vice President, Finance
5,000   Disposition at $13 per share. 65,000
08/29/2018 Daniel Menold
Vice President, Finance
5,000   Derivative/Non-derivative trans. at $5 per share. 25,000
07/27/2018 Sujal Shah
Chief Executive Officer; Director
5,000   Acquisition at $10.9 per share. 54,500

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
2 Purchases
0 Sales
8,100
0

Officers and Executives

Mr. Sujal Shah
President, Chief Executive Officer & Director
Dr. Charles A. McWherter
Chief Scientific Officer & Senior Vice President
Mr. Patrick J. O'Mara
Senior Vice President-Business Development
Mr. Daniel Menold
Vice President-Finance
Ms. Klara A. Dickinson-Eason
Chief Regulatory & Compliance Officer
Dr. Patricia Rohane
Vice President-Clinical Development
Mr. Kenneth F. Boehm
Vice President-Human Resources
Dr. Robert James Wills
Chairman
Mr. Konrad Hans von Emster
Independent Director
Mr. Paul F. Truex
Independent Director
Ms. Caroline M. Loewy
Independent Director
Link to MarketWatch's Slice.